Mercey Livingston is a health and wellness writer and certified Integrative Nutrition Health Coach. She's written about fitness and wellness for Well+Good, Women's Health, Business Insider, and ...
Glucotrack, Inc. (Nasdaq: GCTK) (“Glucotrack” or the “Company”), a medical technology company focused on the design, development, and commercialization of novel technologies for people with diabetes, ...
The investment comes from Dexcom, Google Ventures and Blue Cross Blue Shield of Alabama, with availability to purchase the ...
A continuous glucose monitor is a better option than pricking your finger daily. These wearable devices are stuck to your arm and connect to an app on your smartphone or Apple Watch to easily test ...
Share on Pinterest The Signos system can be used alone, in combination with, or after GLP-1 drugs or bariatric surgery. Photography courtesy of Signos The FDA cleared the first glucose monitoring ...
Blood glucose monitor with packaging, box of test strips, automatic lancing device, lancets, check paddle, quick reference cards, Clinilog record book, important notice card, user's guide, "Diabetes ...
FDA Approves First OTC Glucose Monitor, Dexcom’s Stelo System – and it can Pair with your Smartphone
A breakthrough for diabetes management arrived on March 6th with the FDA‘s approval of Dexcom’s Stelo glucose biosensor system. This revolutionary device, the first of its kind, allows for ...
RUTHERFORD, N.J., June 04, 2025 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK), a medical device company focused on the design, development, and commercialization of novel technologies for people ...
(RTTNews) - Glucotrack, Inc. (GCTK), Wednesday, announced the results from its first-in-human trial of its continuous blood glucose monitoring or CBGM system, which will be presented at the 2025 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results